Claritin
NDC 70264-030, Loratadine, tablet, from R J General Corporation.
- Product NDC
- 70264-030
- Status
- Listed
- Labeler
- R J General Corporation
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA019658
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70264-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LORATADINE10 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70264-030-01 | 70264003001 | 25 POUCH in 1 CARTON (70264-030-01) / 1 TABLET in 1 POUCH |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 70264-030 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70264-030 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70264-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.